Algert Global LLC Homology Medicines, Inc. Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$1.55 - $3.01 $10,168 - $19,745	-6,560 Reduced 15.79%	34,976 $56,000
Q2 2022 Aug 15, 2022	BUY	$1.39 - $3.12 $7,061 - $15,849	5,080 Added 13.93%	41,536 $82,000
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $81,699 - $131,033	-31,423 Reduced 46.29%	36,456 $111,000
Q4 2021 Feb 14, 2022	SELL	$3.64 - $7.78 $48,776 - $104,252	-13,400 Reduced 16.49%	67,879 $247,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $412,941 - $598,455	68,709 Added 546.61%	81,279 $640,000

Q2 2021 Aug 13, 2021	BUY	$6.02 - $9.64 $75,671 - $121,174	12,570 New	12,570 $91,000
Q4 2020 Feb 12, 2021	SELL	$8.92 - $13.29 $279,998 - $417,173	-31,390 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $312,016 - $520,760	31,390 New	31,390 $336,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.